Academic literature on the topic 'HCV'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HCV.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HCV"

1

CRAMP, M. E. "HBV + HCV = HCC?" Gut 45, no. 2 (1999): 168–69. http://dx.doi.org/10.1136/gut.45.2.168.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Paula, Cácia Régia de, Karynne Borges Cabral, Hildete Oliveira Ferreira Dos Prazeres, et al. "Tendência temporal das hepatites virais: A, B, C e B+ C, no estado de Goiás: estudo ecológico." CONTRIBUCIONES A LAS CIENCIAS SOCIALES 18, no. 2 (2025): e15300. https://doi.org/10.55905/revconv.18n.2-111.

Full text
Abstract:
Este estudo teve como objetivo, avaliar a tendência das notificações de hepatite viral A (HAV), hepatite viral B (HBV), hepatite viral C (HCV), e coinfecção de HBV + HCV. Trata-se de estudo de série temporal com dados secundários das notificações de hepatites virais: HAV, HBV, HCV e coinfecção de HBV + HCV em Goiás, entre os anos de 2010 e 2020. Os dados foram obtidos do SINAN, disponibilizados pelo DATASUS. As variáveis sociodemográficas analisadas incluíram sexo e faixa etária. As análises de tendência da série temporal foram realizadas por regressão linear pelo método de Prais-Winsten com v
APA, Harvard, Vancouver, ISO, and other styles
3

Mujeeb, Syed Abdul, Qamar Jamal, Rafique Khanani, Nayyer Iqbal, and Shahnaz Kaher. "Prevalence of Hepatitis B Surface Antigen and HCV Antibodies in Hepatocellular Carcinoma Cases in Karachi, Pakistan." Tropical Doctor 27, no. 1 (1997): 45–46. http://dx.doi.org/10.1177/004947559702700117.

Full text
Abstract:
Hepatocellular carcinoma (HCC) is a common cancer the world over. In Pakistan it has an incidence of 8/100 000 per annum. To assess the prevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections in biopsy proven cases of HCC a serological study was conducted at Screening Laboratory of Blood Transfusion Services, Jinnah Postgraduate Medical Centre. Of 54 sera of HCC tested for HBV and HCV infections, 67% showed HBV infection, and 33% HCV infection. Among them 24% were positive for both HBV and HCV infections. No HBV and HCV infection was found in 24% cases of HCC. Our findings
APA, Harvard, Vancouver, ISO, and other styles
4

Stroffolini, Tommaso, and Giacomo Stroffolini. "A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma." Cancers 15, no. 8 (2023): 2388. http://dx.doi.org/10.3390/cancers15082388.

Full text
Abstract:
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading cause of hepatocellular carcinoma (HCC) worldwide. Currently, HBV-related HCC predominates in Sub-Saharan Africa and South-East-Asia, while HCV-related HCC predominates in northern Africa and in the western world. Liver cirrhosis is the underlying condition in most HBV cases and in nearly all HCV cases. Several cofactors, viral and non-viral, play a role in the progression toward HCC: dual HBV/HCV infection, HDV, HIV, alcohol intake, smoking, diabetes mellitus, obesity, and NAFLD/NASH. HBV vaccine is effective in preventing bo
APA, Harvard, Vancouver, ISO, and other styles
5

Huang, Yen-Tsung, Chin-Lan Jen, Hwai-I. Yang, et al. "Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C." Journal of Clinical Oncology 29, no. 27 (2011): 3643–50. http://dx.doi.org/10.1200/jco.2011.36.2335.

Full text
Abstract:
PurposeBoth hepatitis B (HBV) and C viruses (HCV) are causes of hepatocellular carcinoma (HCC), but lifetime risk and sex difference remain unclear. This study aimed to assess the lifetime risk and sex difference of HCC among patients with chronic HBV and/or HCV.MethodsA prospective cohort of 23,820 residents of Taiwan age 30 to 65 years were enrolled from 1991 to 1992, with 477 instances of HCC occurring subsequently. Serum samples collected at enrollment were tested for seromarkers and viral load of HBV and HCV. Newly developed HCC was ascertained through computerized data linkage with natio
APA, Harvard, Vancouver, ISO, and other styles
6

Pár, Alajos. "Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma." Orvosi Hetilap 150, no. 1 (2009): 19–26. http://dx.doi.org/10.1556/oh.2009.28529.

Full text
Abstract:
Mivel a hepatitis B- és C-vírus- (HBV-, HCV-) fertőzés döntő szerepet játszik a hepatocellularis carcinoma (HCC) keletkezésében, a HBV és HCV okozta hepatitis és cirrhosis megelőzése és kezelése egyben a HCC prevencióját is jelentheti. A HCC primer prevencióját képviseli a HBV elleni vakcináció és a donorok szűrése HBV- és HCV-markerekre. A szekunder prevencióhoz sorolható az interferonalapú és/vagy nukleozidanalóg anti-HBV- és anti-HCV-terápia, a cirrhosisos betegek HCC irányában történő alfa-foetoprotein + ultrahang szűrése, valamint a HCC kuratív reszekciója/ablatiója utáni adjuváns antivir
APA, Harvard, Vancouver, ISO, and other styles
7

Haberl, Elisabeth M., Thomas S. Weiss, Georg Peschel, et al. "Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma." International Journal of Molecular Sciences 22, no. 10 (2021): 5297. http://dx.doi.org/10.3390/ijms22105297.

Full text
Abstract:
Hepatocellular carcinoma (HCC) still remains a difficult to cure malignancy. In recent years, the focus has shifted to lipid metabolism for the treatment of HCC. Very little is known about hepatitis B virus (HBV) and C virus (HCV)-related hepatic lipid disturbances in non-malignant and cancer tissues. The present study showed that triacylglycerol and cholesterol concentrations were similar in tumor adjacent HBV and HCV liver, and were not induced in the HCC tissues. Higher levels of free cholesterol, polyunsaturated phospholipids and diacylglycerol species were noted in non-tumorous HBV compar
APA, Harvard, Vancouver, ISO, and other styles
8

Fang, Lily, Amanda Yu, and Jane A. Buxton. "Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007." Canadian Journal of Infectious Diseases and Medical Microbiology 22, no. 1 (2011): 10–14. http://dx.doi.org/10.1155/2011/564290.

Full text
Abstract:
BACKGROUND: In British Columbia (BC), hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccines are provincially funded for persons with chronic hepatitis infections. PURPOSE: To assess the effectiveness of BC public health follow-up of HBV and hepatitis C virus (HCV) cases and immunization policy by determining the number of vaccine-preventable acute hepatitis infections reported following a chronic HBV or HCV diagnosis, by examining demographic characteristics and by observing temporal trends.METHODS: All newly identified cases of HAV, HBV and HCV between 1991 and October 2007 were extrac
APA, Harvard, Vancouver, ISO, and other styles
9

Buxton, Jane A., and Jin Hee Kim. "Hepatitis A and Hepatitis B Vaccination Responses in Persons with Chronic Hepatitis C Infections: A Review of the Evidence and Current Recommendations." Canadian Journal of Infectious Diseases and Medical Microbiology 19, no. 2 (2008): 197–202. http://dx.doi.org/10.1155/2008/410362.

Full text
Abstract:
In persons with chronic hepatitis C virus (HCV) infections, superinfection by hepatitis A virus (HAV) or hepatitis B virus (HBV) can cause serious complications, including fulminating hepatitis or increased severity of hepatitis. Therefore, it is important to adequately protect persons with chronic HCV infections by immunization. Suboptimal response to vaccines has been reported in patients with chronic liver disease. The present article reviews HAV and HBV vaccine responses reported in the literature when administered to individuals with chronic HCV infection, and reviews current national and
APA, Harvard, Vancouver, ISO, and other styles
10

Shen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, et al. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection." Journal of Clinical Oncology 40, no. 11 (2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.

Full text
Abstract:
PURPOSE H1-antihistamines (AHs) may exert protective effects against cancer. This study investigated the association of AH use with the risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or dual HBV-HCV virus infection. MATERIALS AND METHODS Patients with HBV, HCV, or dual HBV-HCV infection were enrolled from Taiwan's National Health Insurance Research Database and examined for the period from January 1, 2006, to December 31, 2015. We used the Kaplan-Meier method and Cox proportional hazards regression to evaluate the association between A
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HCV"

1

Soares, Sampaio Aletheia. "Marcadores sorológicos para os vírus da hepatite B e C em pacientes HIV-positivos atendidos no Hospital Universitário Oswaldo Cruz." Universidade Federal de Pernambuco, 2005. https://repositorio.ufpe.br/handle/123456789/7445.

Full text
Abstract:
Made available in DSpace on 2014-06-12T18:32:19Z (GMT). No. of bitstreams: 2 arquivo8105_1.pdf: 1882884 bytes, checksum: e39c1a843287ccbea7f187b84dbe1593 (MD5) license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2005<br>A ocorrência de co-infecção pelo HIV e hepatites B e C tem sido relatada desde a era- HAART (do inglês Highly Active Antinetrovial Therapy), quando a mortalidade nas pessoas infectadas pelo HIV começou diminuir. Como conseqüência do fato de terem as mesmas rotas de transmissão, a co-infecção do HBV ou HCV em pessoas infectadas pel
APA, Harvard, Vancouver, ISO, and other styles
2

Burke, Stephanie. "Generalized Impairment of CD8+ T-cells in HCV Mono- and HIV-HCV Co-infection." Thesis, Université d'Ottawa / University of Ottawa, 2015. http://hdl.handle.net/10393/32770.

Full text
Abstract:
Chronic hepatitis C virus (HCV) infection has global effects on the immune system. CD8+ T-cells, responsible for viral clearance and control, are dysfunctional for as yet unknown reasons. It is hypothesized that IL-7 signaling pathway deficiencies contribute to this impairment. Blood-derived CD8+ T-cells in chronic HCV mono- and HIV-HCV co-infection had lower IL-7-induced activation of STAT5 and production of Bcl-2, and lower proliferation in co-infection, compared to controls. Lower Bcl-2 production was also associated with increased fibrosis. These changes were independent of the IL-7 recep
APA, Harvard, Vancouver, ISO, and other styles
3

Kleefeld, Felix [Verfasser]. "Untersuchung des Einflusses einer Interferon-freien HCV-Eradikation auf neurokognitive Funktionen in HIV/HCV-koinfizierten und HCV-monoinfizierten Patienten / Felix Kleefeld." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2019. http://d-nb.info/1179778103/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gupta, Priyanka. "Host gene expression and its regulation by microRNA in HCV and HIV/HCV co-infection." Thesis, The University of Sydney, 2014. http://hdl.handle.net/2123/11998.

Full text
Abstract:
HCV infection is prevalent and long-term infection may lead to liver cirrhosis and hepatocellular carcinoma (HCC). HIV/HCV co-infection has been shown to accelerate progression of HCV associated liver disease, and HCV in exacerbating hepatotoxicity of antiretroviral therapy. Both viruses are able to manipulate the host gene expression (mRNA) and regulatory (miRNA) machinery. It remains unclear how the regulation of mRNA expression is governed in HCV-infected Peripheral Blood Mononuclear Cells (PBMC) and liver tissue (tumor and non-tumor). This may help explain the cross-talk between PBMC and l
APA, Harvard, Vancouver, ISO, and other styles
5

RUSSO, DARIO. "Diagnosi parallela automatizzata di infezioni virali trasmissibili per via ematica (HIV, HCV, HBV)." Doctoral thesis, Università degli Studi di Milano, 2007. http://hdl.handle.net/2434/33618.

Full text
Abstract:
Automated parallel diagnosis of viral infections transmitted in haematic tract. The aim of this study was to develop a complete system for the identification and quantification of HBV, HCV, HIV using molecular biological techniques by means of Real Time PCR. The first step was to develop a positive control, valid for all considered viruses, absolutely free from risk of infection due to the fact that they are synthetic clones. The second step of this study was to develop a complete kit in basic PCR with detection by gel electrophoresis, to identify specific sequences of viral genomes. This test
APA, Harvard, Vancouver, ISO, and other styles
6

Souza, Iury Oliveira. "Validação de ensaio imunocromatográfico para a detecção múltipla de anticorpos específicos contra HIV, HBV e HCV." reponame:Repositório Institucional da UFBA, 2013. http://www.repositorio.ufba.br/ri/handle/ri/11787.

Full text
Abstract:
Submitted by Hiolanda Rêgo (hiolandar@gmail.com) on 2013-06-10T18:28:37Z No. of bitstreams: 1 Dissertação_ICS_Iury Souza.pdf: 1047267 bytes, checksum: 06bc8acdb629b7e8ae63feab201995ad (MD5)<br>Made available in DSpace on 2013-06-10T18:28:37Z (GMT). No. of bitstreams: 1 Dissertação_ICS_Iury Souza.pdf: 1047267 bytes, checksum: 06bc8acdb629b7e8ae63feab201995ad (MD5)<br>CAPES<br>Cerca de 33,3 milhões de pessoas apresentam infecção pelo Human Immunodeficiency Virus (HIV) no mundo; 180 milhões estão infectados pelo Hepatitis C Virus HCV e estima-se que 360 milhões apresentem infecção ativa pelo H
APA, Harvard, Vancouver, ISO, and other styles
7

Heller, Sophie [Verfasser]. "Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten / Sophie Heller." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1206186070/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hultgren, Catharina. "Immune modulation in chronic HBV and HCV infection /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4255-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Costa, Cintia Bezerra Almeida. "Polimorfismo do HLA-G na coinfecção HIV/HCV." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-21052014-181750/.

Full text
Abstract:
O objetivo geral da pesquisa foi associar os polimorfismos do gene HLA-G (região 3\' NT) com a coinfecção HIV/HCV e com os grupos (HIV, HCV e controles saudáveis). Trata-se de um estudo transversal, comparativo, descritivo. Participaram do estudo, 560 indivíduos, sendo 156 controles saudáveis, 102 coinfetados HIV/HCV, 186 infectados pelo HIV e 116 por HCV. Para a identificação dos polimorfismos, o DNA genômico foi extraído do sangue total e a genotipagem feita por PCR e visualizada em gel de poliacrilamida a 7%, no qual o polimorfismo de 14pb foi identificado, e por sequenciamento os ou
APA, Harvard, Vancouver, ISO, and other styles
10

Uccellini, L. "HOST GENETIC INFLUENCE ON HIV AND HCV INFECTIONS." Doctoral thesis, Università degli Studi di Milano, 2013. http://hdl.handle.net/2434/215587.

Full text
Abstract:
In patients with chronic hepatitis C, the hepatitis C virus (HCV) RNA level is an important predictor of treatment response. To explore the relationship of HCV RNA with viral and demographic factors, as well as IL28B genotype, we examined viral levels in an ethnically diverse group of injection drug users (IDUs). Between 1998 and 2000, the Urban Health Study (UHS) recruited IDUs from street settings in San Francisco Bay area neighborhoods. Participants who were positive by HCV EIA were tested for HCV viremia by a bDNA assay. HCV genotype was determined by sequencing the HCV NS5B region. For a
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HCV"

1

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. Community Prescription Service, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dammacco, Franco, ed. HCV Infection and Cryoglobulinemia. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1705-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Springer-Verlag Italia, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Musharraf, Husain, and Population Council (Bangladesh), eds. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Population Council, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Okita, Kiwamu, ed. HCV and Related Liver Diseases. Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68488-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. International Affairs Directorate, Health Canada, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Okita, Kiwamu, ed. HCV/Oxidative Stress and Liver Disease. Springer Japan, 2003. http://dx.doi.org/10.1007/978-4-431-67005-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

name, No. HCV/oxidative stress and liver disease. Springer, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kiwamu, Okita, ed. HCV/oxidative stress and liver disease. Springer, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sofia, Michael J., ed. HCV: The Journey from Discovery to a Cure. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28400-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HCV"

1

Vachon, Marie-Louise C., Alicia C. Stivala, and Douglas T. Dieterich. "HIV/HCV and HIV/HBV Co-infections." In Mount Sinai Expert Guides: Hepatology. John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118748626.ch7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Weiner, Amy J., Michael M. Thaler, Kevin Crawford, et al. "HCV-positive, HIV-1-negative Mothers Transmit HCV." In Viral Hepatitis and Liver Disease. Springer Japan, 1994. http://dx.doi.org/10.1007/978-4-431-68255-4_118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Coffin, Carla S., and Norah A. Terrault. "Treatment of HCV, HDV, or HIV Coinfection." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4843-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhou, Kali, and Norah A. Terrault. "Treatment of HCV, HDV, or HIV Coinfections." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Terrault, Norah A. "Hepatic Transplantation and HBV, HCV, and HIV Infections." In Sherlock's Diseases of the Liver and Biliary System. John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119237662.ch38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Salmon-Ceron, Dominique, J. E. Arends, C. Leoni, C. Solas, and G. Peytavin. "HIV/HCV Coinfection: Current Challenges." In Viral Hepatitis: Chronic Hepatitis C. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03757-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Perez-Alamino, Rodolfo. "Hepatitis Arthritis: HBV and HCV." In Infections and the Rheumatic Diseases. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-23311-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ingiliz, Patrick, Maud Lemoine, and Yves Benhamou. "Chronic HCV and HIV Coinfection." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pereira, Luis F., John J. Faragon, Antoine Douaihy, and Courtney E. Kandler. "Treatment of Comorbid HIV/HCV." In HIV Psychiatry. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-80665-1_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Angtuaco, Terence L., and Donald M. Jensen. "HBV and HCV Co-Infection." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HCV"

1

Bisht, Shilpi, Neeraj Bisht, Bishwajeet Pandey, Vedant Patil, Sonalika Srivastava, and Anshul Srivastava. "Optimizing HCV Diagnosis and Hospital Resource Management Using Machine Learning Techniques." In 2024 3rd Edition of IEEE Delhi Section Flagship Conference (DELCON). IEEE, 2024. https://doi.org/10.1109/delcon64804.2024.10866596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Li, Hui, and Kexin Liu. "Privacy-Preserving HCV Data Outsourcing Scheme for Initial Diagnosis and Epidemiological Study." In 2024 IEEE 48th Annual Computers, Software, and Applications Conference (COMPSAC). IEEE, 2024. http://dx.doi.org/10.1109/compsac61105.2024.00395.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Conte, Fernanda Lopes, Amanda Alencar Cabral Morais, Nivea Orem de Oliveira Guedes, Mariana Villares Martins, and Álisson Bigolin. "Análise do impacto da ampliação da Rede Nacional de Quantificação da Carga Viral do HIV, HBV e HCV point-of-care no Sistema Único de Saúde." In XIV Congresso da Sociedade Brasileira de DST - X Congresso Brasileiro de AIDS - V Congresso Latino Americano IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/dst-2177-8264-202335s1188.

Full text
Abstract:
A Rede Nacional de Quantificação da Carga Viral Rápida (CVR) do HIV e do vírus da hepatite C (HCV), que utiliza a tecnologia point-of-care GeneXpert (Cepheid®), foi implementada em 22 serviços de saúde em julho de 2019, ofertando os exames em regiões de difícil acesso e com infraestrutura laboratorial limitada. Com a finalidade de aumentar a acessibilidade e a agilidade no diagnóstico e monitoramento dessas infecções no Brasil, iniciou-se, em 2022, a expansão da Rede para novos serviços, indicados pelas coordenações estaduais, e a incorporação do teste de CVR do vírus da hepatite B (HBV). Com
APA, Harvard, Vancouver, ISO, and other styles
4

Matos, William Latosinski, Alessandra Helena da Silva Hellwig, Bernardo Kappaun, et al. "Comparação de desempenho e turnaround time dos sistemas cobas® 5800 e Alinity™ m na determinação da carga viral de HCV e HIV-1 em um laboratório da rede de laboratórios de carga viral do Ministério da Saúde." In Resumos do 56º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2024. https://doi.org/10.5327/1516-3180.142s1.13111.

Full text
Abstract:
Objetivo: O manejo clínico das infecções pelos vírus da hepatite C (HCV) e da imunodeficiência humana tipo 1 (HIV-1) baseia-se na mensuração da carga viral no sangue. No sistema de saúde pública brasileiro, a carga viral é realizada pela Rede Nacional de Laboratórios de Carga Viral (RNLCV), que recentemente incorporou os sistemas cobas® 4800/5800, substituindo o sistema Alinity™ m. Avaliar o desempenho e o turnaround time do sistema cobas® 5800 em comparação ao sistema Alinity™ para determinação de carga viral do HCV e do HIV-1 em um laboratório da RNLCV. Método: Estudo transversal retrospecti
APA, Harvard, Vancouver, ISO, and other styles
5

BUZUTTI, P. C., and F. M. T. BINHARDI. "IMPLICAÇÕES DA CO-INFECÇÃO DA DENGUE EM PACIENTES CRONICAMENTE INFECTADOS PELOS VÍRUS HBV E HCV NA REGIÃO DE SÃO JOSÉ DO RIO PRETO-SP." In III Mostra Dos Trabalhos De Conclusão De Curso Da Especialização Em Vigilância Laboratorial Em Saúde Pública. Agron Science, 2022. http://dx.doi.org/10.53934/101021-2.

Full text
Abstract:
Dengue é uma doença tropical febril aguda de extrema importância para a saúde pública. Outro importante agravo são as hepatites virais, que se manifestam de forma aguda ou crônica e infectam milhões de pessoas. As manifestações da dengue em uma população com alta prevalência de HBV e HCV foram pouco estudadas, apesar de estudos mostrarem que uma co-infecção entre elas pode mascarar ou complicar os sintomas. Neste estudo avaliou-se as manifestações e evoluções clínicas em pacientes portadores de HBV e HCV, co-infectados com DENV na região de S. J. Rio Preto-SP, entre 2009 a 2016. Foram comparad
APA, Harvard, Vancouver, ISO, and other styles
6

Giordani, L., FG Cavatão, GM Rodrigues, et al. "AVALIAÇÃO DO TURNAROUND TIME (TAT) E VERIFICAÇÃO DE DESEMPENHO DO ANALISADOR ALINITYTM M EM RELAÇÃO AO M2000SP/RT PARA A DETECÇÃO QUALITATIVA DE SARS-COV-2 E QUANTIFICAÇÃO DE CARGA VIRAL DE HIV-1 E HCV EM UM LABORATÓRIO ASSISTENCIAL." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.5876.

Full text
Abstract:
Objetivo: Avaliar o desempenho do sistema Alinity™ m comparado com o sistema Real Time m2000 (Abbott Molecular Inc., EUA), bem como o impacto da mudança de plataforma para a detecção de Sars-CoV-2 e a quantificação de HIV-1 e HCV na rotina laboratorial por meio da comparação do turnaround time (TAT) para a liberação dos resultados. Método: Foram avaliados a concordância entre os métodos e o desempenho dos ensaios para HIV-1, HCV e Sars-CoV-2. A análise do fluxo de trabalho foi realizada comparando os TATs quando os testes foram processados no m2000 (1º a 31 de março de 2021) e após a implement
APA, Harvard, Vancouver, ISO, and other styles
7

Oliveira, KG, TSP Domingues, S. Pugliese, et al. "INCIDÊNCIA DE CASOS DE HEPATITES VIRAIS AGUDAS A, B, C, D, E EM SERVIÇOS DE SAÚDE BRASILEIROS." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.6928.

Full text
Abstract:
Objetivo: Hepatites virais (HV) são doenças infecciosas de notificação compulsória, e o conhecimento dos padrões atuais de incidência da forma aguda nas diferentes regiões do país é fundamental para a elaboração das políticas públicas de interrupção das cadeias de transmissão. Dessa forma, este estudo tem como objetivo determinar as taxas de incidências das HV A, B, C, D e E em pacientes com quadros clínicos sugestivos de hepatopatia aguda atendidos em algumas instituições de saúde brasileiras participantes de um projeto PROADI junto ao DCCI/SVS/MS. Método: Estudo observacional, prospectivo e
APA, Harvard, Vancouver, ISO, and other styles
8

Yarraguntla, Nireekshith, Naveena Tirumala, Syed Shameem, and K. srinivasa rao. "Detection of Hepatitis viruses (HBV, HAV, HCV) in serum using MEMS based Bio-Sensor." In 2018 Second International Conference on Computing Methodologies and Communication (ICCMC). IEEE, 2018. http://dx.doi.org/10.1109/iccmc.2018.8487679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ferreira da Silva, Giovanna, Marcello do Couto Dias, Irley Karoline Seixas Paiva, Mércia Ferreira Ribeiro, Katarine Antonia dos Santos Barile, and Carlos Eduardo de Melo Amaral. "AVALIAÇÃO DO TESTE SUPLEMENTAR GEENIUS HCV SUPPLEMENTAL ASSAY NA DISPARIDADE ENTRE RESULTADO DE TRIAGEM SOROLÓGICO-MOLECULAR PARA O VÍRUS DA HEPATITE C." In Congresso Brasileiro de Inovação em Microbiologia. Congresse.me, 2022. http://dx.doi.org/10.54265/rnfk1700.

Full text
Abstract:
INTRODUÇÃO: A detecção de HCV na triagem, em doadores de sangue da Fundação Hemopa, é realizada simultaneamente por um teste sorológico e um teste molecular. No caso de discordância entre estes, é realizado um teste confirmatório. Geenius HCV Supplemental Assay é utilizado como teste confirmatório suplementar para análise da presença de anticorpos específicos para HCV, utilizando os antígenos específicos NS3, NS4, NS5 e capsídeo. OBJETIVO: Determinar a freqüência de resultado de imunocromatografia Geenius HCV Confirmatory Assay (BioRad) em amostras Eclesys Anti-HCV reagentes (positivos e incon
APA, Harvard, Vancouver, ISO, and other styles
10

Pedrotti, Luana Giongo, Suelen Porto Basgalupp, Thayane Martins Dornelles, et al. "Análise do perfil epidemiológico da população com hepatites B e C: Estudo SIM." In XIV Congresso da Sociedade Brasileira de DST - X Congresso Brasileiro de AIDS - V Congresso Latino Americano IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/dst-2177-8264-202335s1091.

Full text
Abstract:
Introdução: As hepatites B e C estão entre as principais causas de doenças hepáticas, sendo uma relevante questão de saúde pública em razão de sua morbidade e custos ao sistema de saúde. A maioria dos casos apresenta sintomas apenas em estágios avançados. É necessário conhecer o perfil da população a fim de implementar estratégias de promoção à saúde e de rastreamento precoce. Objetivo: Avaliar o perfil epidemiológico dos indivíduos com hepatites B e C no município de Porto Alegre. Métodos: Estudo transversal realizado na unidade móvel do Estudo SIM entre março de 2020 e junho de 2023. Todos o
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HCV"

1

ตั้งกิจวานิชย์, พิสิฐ, อัญชลี อวิหิงสานนท์, วรพจน์ ทรัพย์ศิริสวัสดิ์ та ін. การศึกษาธรรมชาติการดำเนินโรคของการติดเชื้อไวรัสตับอักเสบซี ความสำคัญทางคลินิคปัจจัยที่เกี่ยวข้องในการรักษาการตอบสนองต่อการรักษา และผลข้างเคียงในผู้ติดเชื้อเอชไอวีที่มีการติดเชื้อไวรัสตับอักเสบซี. จุฬาลงกรณ์มหาวิทยาลัย, 2015. https://doi.org/10.58837/chula.res.2015.24.

Full text
Abstract:
การศึกษานี้เป็นแบบไปข้างหน้าในผู้ป่วยที่ติดเชื้อเอชไอวีร่วมกับการติดเชื้อไวรัสตับอักเสบซีในพื้นที่กรุงเทพมหานคร ประเทศไทย โดยมีการตรวจสายพันธุ์ของไวรัสตับอักเสบซี ปริมาณไวรัสตับอักเสบซีในเลือด ยีน IL-288 และการเกิดพังผืดในตับด้วยเครื่องไฟโบรสแกน และได้แบ่งระยะของพังผืดในตับได้ดังนี้ ระยะแรก (Metavir F0-F1) เป็นระยะที่มีค่า stiffness น้อยกว่าหรือเท่ากับ 7.1 kPa ระยะที่ 2 หรือระยะปานกลาง (F2) เป็นระยะที่มีค่า stiffness ระหว่าง 7.2-9.4 kPa ระยะที่ 3 หรือระยะรุนแรง (F3) เป็นระยะที่มีค่า stiffness ระหว่าง 9.5-14 kPa และระยะสุดท้าย (F4) หรือ โรคตับแข็งที่มีค่า stiffness มากกว่า 14 kPa การตรวจประเมิน
APA, Harvard, Vancouver, ISO, and other styles
2

Hung, Hsuan-Yu, and Chung-Yu Chen. The impact of Sofosbuvir/Velpatasvir/Voxilaprevir treatment on serum hyperglycemia in HCV infections: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0109.

Full text
Abstract:
Review question / Objective: To assess the possible cause of events, the incidence of grade 3 hyperglycemia after treating Sofosbuvir/Velpatasvir/Voxilaprevir in HCV infections. Condition being studied: Sofosbuvir, velpatasvir, and voxilaprevir (SOF/VEL/VOX) is an effective, safe rescue therapy regimen for patients have previously been treated failure. Initiating Direct-Acting Antiviral (DAA) treatment for HCV infection with diabetes have experienced hypoglycemia, it could improve insulin resistance due to clean HCV. However, some studies shown that SOF/VEL/VOX has Grade 3 hyperglycemia advers
APA, Harvard, Vancouver, ISO, and other styles
3

Miller, Sarah, Autumn Spight, Mahogany Freeman, and Sharon Little. Monitoring Adherence to HCV Screening Among the Baby Boomer Population. University of Tennessee Health Science Center, 2022. http://dx.doi.org/10.21007/con.dnp.2022.0040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

ภู่วรวรรณ, ยง. โครงการศึกษาความชุกและลักษณะทางโมเลกุลของไวรัสตับอักเสบชนิด เอ บี และซี ในแรงงานต่างด้าว (พม่า กัมพูชา และลาว) ในประเทศไทย : รายงานการวิจัย. จุฬาลงกรณ์มหาวิทยาลัย, 2009. https://doi.org/10.58837/chula.res.2009.22.

Full text
Abstract:
ปัจจุบันอุบัติการณ์ของเชื้อไวรัสตับอักเสบ เอ บี และซี ในประเทศเพื่อนบ้าน พม่า กัมพูชา และลาว ยังมีข้อมูลน้อยมากหรือมีไม่เพียงพอโดยเฉพาะในแนวลึก งานวิจัยนี้มีจุดประสงค์หาความชุก และจีโนไทป์ของเชื้อไวรัสตับอักเสบ เอ บี และซี ของแรงงานต่างด้าวในประเทศไทย ตรวจหา mutation ของไวรัสในบริเวณส่วนของยีนที่สนใจ เพื่อเป็นแนวทางในการบอกวิวัฒนาการและเป็นข้อมูลพื้นฐานที่จะใช้ในการป้องกันโรคให้กับคนไทยในอนาคต ไวรัสตับอักเสบ เอ: ตัวอย่างชาวต่างด้าวทั้งหมด 1,183 คน (394 คน, 394 คน จากชาวพม่า กัมพูชา และลาวตามลำดับ) เป็นเพศชาย 594 คน เพศหญิง 589 คน อายุโดยเฉลี่ย 28.1 ปี (ค่าความแปรปรวนมาตรฐานเท่ากับ 9 ปี) จากการ
APA, Harvard, Vancouver, ISO, and other styles
5

Tsai, Tsung-Yu, Guan-Jhou Chen, Hsin-Yun Sun, and Chien-Ching Hung. Diagnostic Performance of Hepatitis C Virus Core Antigen for Acute HCV Infection among People with HIV: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.3.0106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Full text
Abstract:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
APA, Harvard, Vancouver, ISO, and other styles
7

Mensch, Barbara, and Erica Soler-Hampejsek. Characteristics associated with HIV and HSV-2 among adolescents in Malawi. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mensch, Barbara, and Erica Soler-Hampejsek. Rates of HIV and HSV-2 among young people in Machinga, Malawi. Population Council, 2017. http://dx.doi.org/10.31899/hiv6.1027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, Lynette M., Nicholas A. Hein, and Danstan S. Bagenda. Cash transfers and HIV/HSV-2 prevalence: a replication of a cluster randomized trial in Malawi. International Initiative for Impact Evaluation (3ie), 2017. http://dx.doi.org/10.23846/rps0012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yu, Fang, Nicholas A. Hein, and Danstan S. Bagenda. Preventing HIV and HSV-2 through improving knowledge and attitudes: a replication study of a multicomponent intervention in Zimbabwe. International Initiative for Impact Evaluation (3ie), 2018. http://dx.doi.org/10.23846/rps0016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!